{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T07:39:50Z","timestamp":1783409990308,"version":"3.54.6"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T00:00:00Z","timestamp":1482192000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007476","name":"Canadian Diabetes Association","doi-asserted-by":"publisher","award":["OG-3-11-3413-CV"],"award-info":[{"award-number":["OG-3-11-3413-CV"]}],"id":[{"id":"10.13039\/100007476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-14682"],"award-info":[{"award-number":["MOP-14682"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00125-016-4174-2","type":"journal-article","created":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T16:32:56Z","timestamp":1482251576000},"page":"453-463","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Loss of prohormone convertase 2 promotes beta cell dysfunction in a rodent transplant model expressing human pro-islet amyloid polypeptide"],"prefix":"10.1007","volume":"60","author":[{"given":"Jaques A.","family":"Courtade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek L.","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Soukhatcheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Orban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Bruce","family":"Verchere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,20]]},"reference":[{"key":"4174_CR1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","volume":"52","author":"AE Butler","year":"2003","unstructured":"Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) \u03b2-Cell deficit and increased \u03b2-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102\u2013110","journal-title":"Diabetes"},{"key":"4174_CR2","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/diab.39.5.634","volume":"39","author":"SE Kahn","year":"1990","unstructured":"Kahn SE, D\u2019Alessio DA, Schwartz MW et al (1990) Evidence of cosecretion of islet amyloid polypeptide and insulin by \u03b2-cells. Diabetes 39:634\u2013638","journal-title":"Diabetes"},{"key":"4174_CR3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0167-0115(93)90362-C","volume":"45","author":"M Stridsberg","year":"1993","unstructured":"Stridsberg M, Sandler S, Wilander E (1993) Cosecretion of islet amyloid polypeptide (IAPP) and insulin from isolated rat pancreatic islets following stimulation or inhibition of beta-cell function. Regul Pept 45:363\u2013370","journal-title":"Regul Pept"},{"key":"4174_CR4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/(SICI)1096-9896(199608)179:4<443::AID-PATH612>3.0.CO;2-7","volume":"179","author":"SBP Charg\u00e9","year":"1996","unstructured":"Charg\u00e9 SBP, Esiri MM, Bethune CA, Hansen BC, Clark A (1996) Apolipoprotein E is associated with islet amyloid and other amyloidoses: implications for Alzheimer\u2019s disease. J Pathol 179:443\u2013447","journal-title":"J Pathol"},{"key":"4174_CR5","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1073\/pnas.91.12.5602","volume":"91","author":"MB Pepys","year":"1994","unstructured":"Pepys MB, Rademacher TW, Amatayakul-Chantler S et al (1994) Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc Natl Acad Sci U S A 91:5602\u20135606","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4174_CR6","doi-asserted-by":"crossref","first-page":"9228","DOI":"10.1021\/bi0510936","volume":"45","author":"A Abedini","year":"2006","unstructured":"Abedini A, Tracz SM, Cho JH, Raleigh DP (2006) Characterization of the heparin binding site in the N-terminus of human pro-islet amyloid polypeptide: implications for amyloid formation. Biochemistry 45:9228\u20139237","journal-title":"Biochemistry"},{"key":"4174_CR7","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.2337\/db06-1579","volume":"56","author":"CY Lin","year":"2007","unstructured":"Lin CY, Gurlo T, Kayed R et al (2007) Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h-IAPP-induced \u03b2-cell apoptosis in h-IAPP transgenic mice. Diabetes 56:1324\u20131332","journal-title":"Diabetes"},{"key":"4174_CR8","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed R (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486\u2013489","journal-title":"Science"},{"key":"4174_CR9","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ni.1935","volume":"11","author":"SL Masters","year":"2010","unstructured":"Masters SL, Dunne A, Subramanian SL et al (2010) Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1\u03b2 in type 2 diabetes. Nat Immunol 11:897\u2013904","journal-title":"Nat Immunol"},{"key":"4174_CR10","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.4049\/jimmunol.1002854","volume":"187","author":"C Westwell-Roper","year":"2011","unstructured":"Westwell-Roper C, Dai DL, Soukhatcheva G et al (2011) IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction. J Immunol 187:2755\u20132765","journal-title":"J Immunol"},{"key":"4174_CR11","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.2337\/db13-0863","volume":"63","author":"CY Westwell-Roper","year":"2014","unstructured":"Westwell-Roper CY, Ehses JA, Verchere CB (2014) Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1\u03b2 production and \u03b2-cell dysfunction. Diabetes 63:1698\u20131711","journal-title":"Diabetes"},{"key":"4174_CR12","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1073\/pnas.0909024107","volume":"107","author":"KJ Potter","year":"2010","unstructured":"Potter KJ, Abedini A, Marek P et al (2010) Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts. Proc Natl Acad Sci U S A 107:4305\u20134310","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4174_CR13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00125-008-1185-7","volume":"52","author":"J Udayasankar","year":"2009","unstructured":"Udayasankar J, Kodama K, Hull RL et al (2009) Amyloid formation results in recurrence of hyperglycaemia following transplantation of human IAPP transgenic mouse islets. Diabetologia 52:145\u2013153","journal-title":"Diabetologia"},{"key":"4174_CR14","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.2337\/db05-1672","volume":"55","author":"AV Matveyenko","year":"2006","unstructured":"Matveyenko AV, Butler PC (2006) \u03b2-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes. Diabetes 55:2106\u20132114","journal-title":"Diabetes"},{"key":"4174_CR15","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/BF00296991","volume":"30","author":"WK Ward","year":"1987","unstructured":"Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, Porte D Jr (1987) Disproportionate elevation of immunoreactive proinsulin in Type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 30:698\u2013702","journal-title":"Diabetologia"},{"key":"4174_CR16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/(SICI)1096-9136(199608)13:8<753::AID-DIA163>3.0.CO;2-Z","volume":"13","author":"DK Nagi","year":"1996","unstructured":"Nagi DK, Ali VM, Yudkin JS (1996) Effect of metformin on intact proinsulin and des 31,32 proinsulin concentrations in subjects with non-insulin-dependent (Type 2) diabetes mellitus. Diabet Med 13:753\u2013757","journal-title":"Diabet Med"},{"key":"4174_CR17","doi-asserted-by":"crossref","first-page":"10299","DOI":"10.1073\/pnas.162352799","volume":"99","author":"X Zhu","year":"2002","unstructured":"Zhu X, Orci L, Carroll R, Norrbom C, Ravazzola M, Steiner DF (2002) Severe block in processing of proinsulin to insulin accompanied by elevation of des-64,65 proinsulin intermediates in islets of mice lacking prohormone convertase 1\/3. Proc Natl Acad Sci U S A 99:10299\u201310304","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4174_CR18","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/j.1600-6143.2009.02740.x","volume":"9","author":"AM Klimek","year":"2009","unstructured":"Klimek AM, Soukhatcheva G, Thompson DM et al (2009) Impaired proinsulin processing is a characteristic of transplanted islets. Am J Transplant 9:2119\u20132125","journal-title":"Am J Transplant"},{"key":"4174_CR19","doi-asserted-by":"crossref","first-page":"10293","DOI":"10.1073\/pnas.162352599","volume":"99","author":"X Zhu","year":"2002","unstructured":"Zhu X, Zhou A, Dey A et al (2002) Disruption of PC1\/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects. Proc Natl Acad Sci U S A 99:10293\u201310298","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4174_CR20","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1073\/pnas.94.13.6646","volume":"94","author":"M Furuta","year":"1997","unstructured":"Furuta M, Yano H, Zhou A et al (1997) Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. Proc Natl Acad Sci 94:6646\u20136651","journal-title":"Proc Natl Acad Sci"},{"key":"4174_CR21","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1074\/jbc.273.6.3431","volume":"273","author":"M Furuta","year":"1998","unstructured":"Furuta M, Carroll R, Martin S et al (1998) Incomplete processing of proinsulin to insulin accompanied by elevation of Des-31,32 proinsulin intermediates in islets of mice lacking active PC2. J Biol Chem 273:3431\u20133437","journal-title":"J Biol Chem"},{"key":"4174_CR22","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1016\/S0021-9258(19)43799-X","volume":"248","author":"SS Yu","year":"1973","unstructured":"Yu SS, Kitbachi AE (1973) Biological activity of proinsulin and related polypeptides in the fat tissue. J Biol Chem 248:3753\u20133761","journal-title":"J Biol Chem"},{"key":"4174_CR23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diabetes.53.1.141","volume":"53","author":"L Marzban","year":"2004","unstructured":"Marzban L, Trigo-Gonzalez G, Zhu X et al (2004) Role of \u03b2-cell prohormone convertase (PC) 1\/3 in processing of pro-islet amyloid polypeptide. Diabetes 53:141\u2013148","journal-title":"Diabetes"},{"key":"4174_CR24","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2337\/diabetes.50.3.534","volume":"50","author":"J Wang","year":"2001","unstructured":"Wang J, Xu J, Finnerty J, Furuta M, Steiner DF, Verchere CB (2001) The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptide at the NH2-terminal cleavage site. Diabetes 50:534\u2013539","journal-title":"Diabetes"},{"key":"4174_CR25","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jinorgbio.2010.05.012","volume":"104","author":"C Exley","year":"2010","unstructured":"Exley C, House E, Patel T, Wu L, Fraser PE (2010) Human pro-islet amyloid polypeptide (ProIAPP(1\u201348)) forms amyloid fibrils and amyloid spherulites in vitro. J Inorg Biochem 104:1125\u20131129","journal-title":"J Inorg Biochem"},{"key":"4174_CR26","doi-asserted-by":"crossref","first-page":"10918","DOI":"10.1021\/bi901076d","volume":"48","author":"L Khemt\u00e9mourian","year":"2009","unstructured":"Khemt\u00e9mourian L, Casarramona GL, Suylen DPL et al (2009) Impaired processing of human pro-islet amyloid polypeptide is not a causative factor for fibril formation or membrane damage in vitro. Biochemistry 48:10918\u201310925","journal-title":"Biochemistry"},{"key":"4174_CR27","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1210\/jc.2007-0687","volume":"92","author":"IS Farooqi","year":"2007","unstructured":"Farooqi IS, Volders K, Stanhope R et al (2007) Hyperphagia and early-onset obesity due to a novel homozygous missense mutation in prohormone convertase 1\/3. J Clin Endocrinol Metab 92:3369\u20133373","journal-title":"J Clin Endocrinol Metab"},{"key":"4174_CR28","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2337\/diabetes.54.7.2117","volume":"54","author":"JF Paulsson","year":"2005","unstructured":"Paulsson JF, Westermark GT (2005) Aberrant processing of human proislet amyloid polypeptide results in increased amyloid formation. Diabetes 54:2117\u20132125","journal-title":"Diabetes"},{"key":"4174_CR29","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.2337\/db05-1566","volume":"55","author":"L Marzban","year":"2006","unstructured":"Marzban L, Rhodes CJ, Steiner DF, Haataja L, Halban PA, Verchere CB (2006) Impaired NH2-terminal processing of human proislet amyloid polypeptide by the prohormone convertase PC2 leads to amyloid formation and cell death. Diabetes 55:2192\u20132201","journal-title":"Diabetes"},{"key":"4174_CR30","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1210\/en.2011-2019","volume":"153","author":"C Alarcon","year":"2012","unstructured":"Alarcon C, Verchere CB, Rhodes CJ (2012) Translational control of glucose-induced islet amyloid polypeptide production in pancreatic islets. Endocrinology 153:2082\u20132087","journal-title":"Endocrinology"},{"key":"4174_CR31","doi-asserted-by":"crossref","first-page":"12091","DOI":"10.1021\/bi7004834","volume":"46","author":"F Meng","year":"2007","unstructured":"Meng F, Abedini A, Song B, Raleigh DP (2007) Amyloid formation by pro-islet amyloid polypeptide processing intermediates: examination of the role of protein heparan sulfate interactions and implications for islet amyloid formation in type 2 diabetes. Biochemistry 46:12091\u201312099","journal-title":"Biochemistry"},{"key":"4174_CR32","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1111\/ajt.13134","volume":"15","author":"KJ Potter","year":"2015","unstructured":"Potter KJ, Werner I, Denroche HC et al (2015) Amyloid formation in human islets is enhanced by heparin and inhibited by heparinase. Am J Transplant 15:1519\u20131530","journal-title":"Am J Transplant"},{"key":"4174_CR33","doi-asserted-by":"crossref","first-page":"16611","DOI":"10.1074\/jbc.M008423200","volume":"276","author":"K Park","year":"2001","unstructured":"Park K, Verchere CB (2001) Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. Implications for islet amyloid formation. J Biol Chem 276:16611\u201316616","journal-title":"J Biol Chem"},{"key":"4174_CR34","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2337\/diabetes.51.2.398","volume":"51","author":"GC Webb","year":"2002","unstructured":"Webb GC, Akbar MS, Zhao C, Swift HH, Steiner DF (2002) Glucagon replacement via micro-osmotic pump corrects hypoglycemia and \u03b1-cell hyperplasia in prohormone convertase 2 knockout mice. Diabetes 51:398\u2013405","journal-title":"Diabetes"},{"key":"4174_CR35","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1007\/s00125-005-1959-0","volume":"48","author":"I Truyen","year":"2005","unstructured":"Truyen I, De Pauw P, J\u00f8rgensen PN et al (2005) Proinsulin levels and the proinsulin:C-peptide ratio complement autoantibody measurement for predicting type 1 diabetes. Diabetologia 48:2322\u20132329","journal-title":"Diabetologia"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-016-4174-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-016-4174-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-016-4174-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T16:15:10Z","timestamp":1658247310000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-016-4174-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,20]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["4174"],"URL":"https:\/\/doi.org\/10.1007\/s00125-016-4174-2","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,20]]}}}